Skip To Main Content
Gaetano Aurilio on Muck Rack

Gaetano Aurilio

As seen in: MDPI, Future Medicine
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Gaetano

Contact Gaetano, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Chemoprevention and Lifestyle Modifications for Risk Reduction in Sporadic and Hereditary Breast Cancer

|
By Davide Serrano, Gaetano Aurilio, Bernardo Bonanni, Matteo Lazzeroni
| MDPI
1. Introduction Female breast cancer is the most commonly diagnosed malignancy worldwide [1]. GLOBOCAN 2020 estimated 2.3 million new cases and 684,996 deaths from breast cancer and showed that female breast cancer surpassed lung cancer as the most commonly diagnosed cancer [1]. One in eight women (12.9%) will develop breast cancer in their lifetime [2,3]. In addition, the burden of breast cancer is rising worldwide in premenopausal and postmenopausal women [1,4].
Open in Who Shared Issue with article?

Image-Guided Ablations in Patients with Recurrent Renal Cell Carcinoma

|
By Gaetano Aurilio, Giovanni Mauri, Duccio Rossi, Paolo Della Vigna
| MDPI
Open AccessArticle by Gaetano Aurilio 1,†, Giovanni Mauri 2,†, Duccio Rossi 2,*, Paolo Della Vigna 2, Guido Bonomo 2, Gianluca Maria Varano 2, Daniele Maiettini 2, Maria Cossu Rocca 3, Elena Verri 3, Daniela Cullurà 3, Franco Nolé 3 and Franco Orsi 2 1 Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia IEO, European Institute of Oncology IRCCS, 20122 Milan, Italy 2 Division of Interventional Radiology, Istituto Europeo di Oncologia IEO, European Institute of Oncology...
Open in Who Shared Issue with article?

Designing novel immunocombinations in metastatic renal cell carcinoma

|
By Matteo Santoni, Francesco Massari, Gaetano Aurilio, Veronica Mollica
| Future Medicine Verified
ImmunotherapyAhead of Print Review , Francesco Massari‡ *Author for correspondence: E-mail Address: fmassari79@gmail.com https://orcid.org/0000-0001-6476-6871 Oncologia Medica, Azienda Ospedaliero-Universitaria di Bologna, Via Albertoni – 15, Bologna – Italia , , , , , , , & Abstract Immune checkpoint inhibitors have radically changed the treatment approach to metastatic renal cell carcinoma (mRCC).
Open in Who Shared Issue with article?
See all 4 articles